Effects of Vitamin B3 in Patients With Ataxia Telangiectasia

Key facts

Sponsor

Radboud University Medical Center

Principal Investigator

Michel Willemsen, Prof.

michel.willemsen@radboudumc.nl

Intervention

Vitamin B3(dietary_supplement)

Enrollment

24 enrolled

Eligibility

2 years · All sexes

Timeline

2019 – 2020

Study locations (1)

• Radboudumc, Nijmegen, Netherlands

Collaborators

A-T Children's Project · Twan foundation (https://twanfoundation.nl)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ataxia-telangiectasia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE3NCT06673056
  A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
  IntraBio Inc
• ACTIVE NOT RECRUITINGPHASE2NCT04870866
  NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
  University Hospital, Akershus

See all trials for Ataxia-telangiectasia →